• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异羟肟酸对鼠伤寒沙门氏菌的致突变性。

Mutagenicity of hydroxamic acids for Salmonella typhimurium.

作者信息

Wang C Y

出版信息

Mutat Res. 1977 Sep;56(1):7-12. doi: 10.1016/0027-5107(77)90235-4.

DOI:10.1016/0027-5107(77)90235-4
PMID:339075
Abstract

P-Butoxyphenylacethydroxamic acid, benzohydroxamic acid, salicylhydroxamic acid, 2-naphthohydroxamic acid, indole-2-carbohydroxamic acid and benzoylaminoacethydroxamic acid were synthesized, and their mutagenicity for Salmonella typhimurium strains TA98 and TA100 were determined. Except for p-butoxyphenylacethydroxamic acid, all the hydroxamic acids were mutagenic for both strains. The mutagenicity progressed in the following order: 2-naphthohydroxamic acid greater than benzohydroxamic acid and salicylhydroxamic acid greater than benzoylaminoacethydroxamic acid and indole-2-carbohydroxamic acid. The starting materials for the synthesis of these acids including hydroxylamine were not in themselves mutagenic for TA98 and TA100. Thus, while the mutagenicity may require the hydroxamic acid as a whole, the acyl group may determine the mutagenic potency.

摘要

合成了对丁氧基苯乙酰异羟肟酸、苯甲酰异羟肟酸、水杨酰异羟肟酸、2-萘甲酰异羟肟酸、吲哚-2-甲酰异羟肟酸和苯甲酰氨基乙酰异羟肟酸,并测定了它们对鼠伤寒沙门氏菌TA98和TA100菌株的致突变性。除对丁氧基苯乙酰异羟肟酸外,所有异羟肟酸对这两种菌株均具有致突变性。致突变性按以下顺序递增:2-萘甲酰异羟肟酸>苯甲酰异羟肟酸和水杨酰异羟肟酸>苯甲酰氨基乙酰异羟肟酸和吲哚-2-甲酰异羟肟酸。合成这些酸所用的起始原料(包括羟胺)本身对TA98和TA100不具有致突变性。因此,虽然致突变性可能需要整个异羟肟酸,但酰基可能决定致突变效力。

相似文献

1
Mutagenicity of hydroxamic acids for Salmonella typhimurium.异羟肟酸对鼠伤寒沙门氏菌的致突变性。
Mutat Res. 1977 Sep;56(1):7-12. doi: 10.1016/0027-5107(77)90235-4.
2
Mutagenicity of pyridine- and quinoline-carbohydroxamic acid derivatives.吡啶和喹啉碳酰异羟肟酸衍生物的致突变性。
Mutat Res. 1984 Mar;135(3):139-48. doi: 10.1016/0165-1218(84)90114-9.
3
Mutagenicity of some commercially available nitro compounds for Salmonella typhimurium.某些市售硝基化合物对鼠伤寒沙门氏菌的致突变性。
Mutat Res. 1978 Sep;58(1):11-22. doi: 10.1016/0165-1218(78)90090-3.
4
Mutagenicity of some monoaromatic hydroxamic acids.某些单芳族异羟肟酸的致突变性。
Toxicol Lett. 1985 Jan;24(1):111-6. doi: 10.1016/0378-4274(85)90148-1.
5
Mutagenicity screening of five methyl carbamate insecticides and their nitroso derivatives using mutants of Salmonella typhimurium LT2.利用鼠伤寒沙门氏菌LT2突变体对五种氨基甲酸甲酯类杀虫剂及其亚硝基衍生物进行致突变性筛选。
Mutat Res. 1977 Sep;56(1):1-6. doi: 10.1016/0027-5107(77)90234-2.
6
Mutagenicity studies with nitrofurans. II. mutagenicity of nitrofurylacrylic acid for Salmonella typhimurium.呋喃类药物的致突变性研究。II. 硝呋烯丙酸对鼠伤寒沙门氏菌的致突变性
Mutat Res. 1980 Jan;77(1):1-12.
7
Mutagenicity to Salmonella typhimurium of some Aspergillus and Penicillium mycotoxins.某些曲霉和青霉霉菌毒素对鼠伤寒沙门氏菌的致突变性。
Mutat Res. 1978 Nov;58(2-3):193-203. doi: 10.1016/0165-1218(78)90009-5.
8
Genotoxic activity of chlorinated butenoic acids in Salmonella typhimurium strains TA98, TA100 and TA104.氯代丁烯酸在鼠伤寒沙门氏菌TA98、TA100和TA104菌株中的遗传毒性活性。
Mutat Res. 1998 Sep 1;417(1):31-7. doi: 10.1016/s1383-5718(98)00092-8.
9
Mutagenicity of nitrophenanthrene derivatives for Salmonella typhimurium: effects of nitroreductase and acetyltransferase.硝基菲衍生物对鼠伤寒沙门氏菌的致突变性:硝基还原酶和乙酰转移酶的作用
Mutat Res. 1996 Jan 17;349(1):137-44. doi: 10.1016/0027-5107(95)00173-5.
10
The mutagenic activity of ethyl N-hydroxycarbamate and its related compounds in Salmonella typhimurium.N-羟基氨基甲酸乙酯及其相关化合物在鼠伤寒沙门氏菌中的致突变活性。
Mutat Res. 1980 Jun;78(2):145-50. doi: 10.1016/0165-1218(80)90093-2.

引用本文的文献

1
Replacement of the hydroxamic acid group in the selective HDAC8 inhibitor PCI-34051.取代选择性 HDAC8 抑制剂 PCI-34051 中的羟肟酸基团。
Bioorg Med Chem Lett. 2024 Aug 1;108:129810. doi: 10.1016/j.bmcl.2024.129810. Epub 2024 May 22.
2
Inhibition of urease-mediated ammonia production by 2-octynohydroxamic acid in hepatic encephalopathy.2-辛炔氧肟酸抑制肝性脑病中尿素酶介导的氨生成。
Nat Commun. 2024 Mar 12;15(1):2226. doi: 10.1038/s41467-024-46481-8.
3
Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases.
非羟肟酸锌结合基团作为组蛋白去乙酰化酶的弹头。
Molecules. 2021 Aug 25;26(17):5151. doi: 10.3390/molecules26175151.
4
A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019).针对神经退行性疾病的组蛋白去乙酰化酶 6 抑制剂的专利审查(2014-2019 年)。
Expert Opin Ther Pat. 2020 Feb;30(2):121-136. doi: 10.1080/13543776.2019.1708901. Epub 2019 Dec 25.
5
Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?为何异羟肟酸酯可能并非最佳的组蛋白去乙酰化酶抑制剂——有些人可能遗忘或宁愿忘却的是什么?
ChemMedChem. 2016 Jan 5;11(1):15-21. doi: 10.1002/cmdc.201500486. Epub 2015 Nov 25.
6
Mutagenicity of new lead compounds to treat sickle cell disease symptoms in a Salmonella/microsome assay.用沙门氏菌/微粒体试验检测新型治疗镰状细胞病症状的铅化合物的致突变性。
Int J Mol Sci. 2010 Feb 25;11(2):779-88. doi: 10.3390/ijms11020779.
7
S.E.M. study of urease-induced crystalluria in the presence of hydroxamic derivatives.异羟肟酸衍生物存在下脲酶诱导结晶尿的扫描电子显微镜研究
Int Urol Nephrol. 1986;18(3):227-33. doi: 10.1007/BF02082708.